166 related articles for article (PubMed ID: 9618411)
1. The contribution of classical (beta1/2-) and atypical beta-adrenoceptors to the stimulation of human white adipocyte lipolysis and right atrial appendage contraction by novel beta3-adrenoceptor agonists of differing selectivities.
Sennitt MV; Kaumann AJ; Molenaar P; Beeley LJ; Young PW; Kelly J; Chapman H; Henson SM; Berge JM; Dean DK; Kotecha NR; Morgan HK; Rami HK; Ward RW; Thompson M; Wilson S; Smith SA; Cawthorne MA; Stock MJ; Arch JR
J Pharmacol Exp Ther; 1998 Jun; 285(3):1084-95. PubMed ID: 9618411
[TBL] [Abstract][Full Text] [Related]
2. Selective activation of beta3-adrenoceptors by octopamine: comparative studies in mammalian fat cells.
Carpéné C; Galitzky J; Fontana E; Atgié C; Lafontan M; Berlan M
Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):310-21. PubMed ID: 10344530
[TBL] [Abstract][Full Text] [Related]
3. Metabolic response to various beta-adrenoceptor agonists in beta3-adrenoceptor knockout mice: evidence for a new beta-adrenergic receptor in brown adipose tissue.
Preitner F; Muzzin P; Revelli JP; Seydoux J; Galitzky J; Berlan M; Lafontan M; Giacobino JP
Br J Pharmacol; 1998 Aug; 124(8):1684-8. PubMed ID: 9756384
[TBL] [Abstract][Full Text] [Related]
4. Lipolytic effects of conventional beta 3-adrenoceptor agonists and of CGP 12,177 in rat and human fat cells: preliminary pharmacological evidence for a putative beta 4-adrenoceptor.
Galitzky J; Langin D; Verwaerde P; Montastruc JL; Lafontan M; Berlan M
Br J Pharmacol; 1997 Nov; 122(6):1244-50. PubMed ID: 9401793
[TBL] [Abstract][Full Text] [Related]
5. Bucindolol exerts agonistic activity on the propranolol-insensitive state of beta1-adrenoceptors in human myocardium.
Bundkirchen A; Brixius K; Bölck B; Schwinger RH
J Pharmacol Exp Ther; 2002 Mar; 300(3):794-801. PubMed ID: 11861783
[TBL] [Abstract][Full Text] [Related]
6. Effects of (-)-RO363 at human atrial beta-adrenoceptor subtypes, the human cloned beta 3-adrenoceptor and rodent intestinal beta 3-adrenoceptors.
Molenaar P; Sarsero D; Arch JR; Kelly J; Henson SM; Kaumann AJ
Br J Pharmacol; 1997 Jan; 120(2):165-76. PubMed ID: 9117106
[TBL] [Abstract][Full Text] [Related]
7. Beta-adrenoceptor subtype expression and function in rat white adipocytes.
Germack R; Starzec AB; Vassy R; Perret GY
Br J Pharmacol; 1997 Jan; 120(2):201-10. PubMed ID: 9117110
[TBL] [Abstract][Full Text] [Related]
8. Impaired expression and functional activity of the beta 3- and beta 1-adrenergic receptors in adipose tissue of congenitally obese (C57BL/6J ob/ob) mice.
Collins S; Daniel KW; Rohlfs EM; Ramkumar V; Taylor IL; Gettys TW
Mol Endocrinol; 1994 Apr; 8(4):518-27. PubMed ID: 7914350
[TBL] [Abstract][Full Text] [Related]
9. Further evidence for differences between cardiac atypical beta-adrenoceptors and brown adipose tissue beta3-adrenoceptors in the pithed rat.
Malinowska B; Schlicker E
Br J Pharmacol; 1997 Dec; 122(7):1307-14. PubMed ID: 9421276
[TBL] [Abstract][Full Text] [Related]
10. Expression of beta3-adrenoceptors with low lipolytic action in human subcutaneous white adipocytes.
Tavernier G; Barbe P; Galitzky J; Berlan M; Caput D; Lafontan M; Langin D
J Lipid Res; 1996 Jan; 37(1):87-97. PubMed ID: 8820105
[TBL] [Abstract][Full Text] [Related]
11. beta1-adrenergic receptors mediate beta3-adrenergic-independent effects of CGP 12177 in brown adipose tissue.
Konkar AA; Zhai Y; Granneman JG
Mol Pharmacol; 2000 Feb; 57(2):252-8. PubMed ID: 10648634
[TBL] [Abstract][Full Text] [Related]
12. Agonist and antagonist properties of beta 3-adrenoceptors in human omental and mouse 3T3-L1 adipocytes.
Shimizu M; Blaak EE; Lonnqvist F; Gafvels ME; Arner P
Pharmacol Toxicol; 1996 Apr; 78(4):254-63. PubMed ID: 8861784
[TBL] [Abstract][Full Text] [Related]
13. Nebivolol induces, via β3 adrenergic receptor, lipolysis, uncoupling protein 1, and reduction of lipid droplet size in human adipocytes.
Bordicchia M; Pocognoli A; D'Anzeo M; Siquini W; Minardi D; Muzzonigro G; Dessì-Fulgheri P; Sarzani R
J Hypertens; 2014 Feb; 32(2):389-96. PubMed ID: 24256707
[TBL] [Abstract][Full Text] [Related]
14. Lipolytic effects of beta1, beta2 and beta3-adrenergic agonists in isolated human fat cells from omental and retroperitoneal adipose tissues.
Portillo MP; Rocandio AM; Garcia-Calonge MA; Diaz E; Campo E; Martinez-Blazquez C; Errasti J; del Barrio AS
Rev Esp Fisiol; 1995 Dec; 51(4):193-200. PubMed ID: 8907433
[TBL] [Abstract][Full Text] [Related]
15. Coexistence of three beta-adrenoceptor subtypes in white fat cells of various mammalian species.
Langin D; Portillo MP; Saulnier-Blache JS; Lafontan M
Eur J Pharmacol; 1991 Jul; 199(3):291-301. PubMed ID: 1680716
[TBL] [Abstract][Full Text] [Related]
16. Desensitization of beta-1 and beta-2, but not beta-3, adrenoceptor-mediated lipolytic responses of adipocytes after long-term norepinephrine infusion.
Carpéné C; Galitzky J; Collon P; Esclapez F; Dauzats M; Lafontan M
J Pharmacol Exp Ther; 1993 Apr; 265(1):237-47. PubMed ID: 8097243
[TBL] [Abstract][Full Text] [Related]
17. Direct evidence for the atypical nature of functional beta-adrenoceptors in rat adipocytes.
Hollenga C; Zaagsma J
Br J Pharmacol; 1989 Dec; 98(4):1420-4. PubMed ID: 2575416
[TBL] [Abstract][Full Text] [Related]
18. Determination of beta 3-adrenoceptor mediated lipolysis in human fat cells.
Hoffstedt J; Shimizu M; Sjöstedt S; Lönnqvist F
Obes Res; 1995 Sep; 3(5):447-57. PubMed ID: 8521164
[TBL] [Abstract][Full Text] [Related]
19. Effects of several putative beta 3-adrenoceptor agonists on lipolysis in human omental adipocytes.
Hoffstedt J; Lönnqvist F; Shimizu M; Blaak E; Arner P
Int J Obes Relat Metab Disord; 1996 May; 20(5):428-34. PubMed ID: 8696421
[TBL] [Abstract][Full Text] [Related]
20. Drop in the "atypical" beta-adrenergic response and modification of the beta/alpha 2-adrenoceptor balance in fat cells from aging rabbits.
Langin D; Portillo M; Dauzats M; Lafontan M
Endocrinology; 1992 Jan; 130(1):307-15. PubMed ID: 1309335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
